Curated industry list

High-Beta Momentum in Biotechnology on NASDAQ

Explore High-Beta Momentum in Biotechnology on NASDAQ. Compare qualifying stocks using fair value, valuation, financial quality, analyst expectations, and market data.

Achieve Life Sciences Inc (ACHV)
Fair Value-38.2% Downside Overvalued Analyst111.6% Upside Market Cap664.2 M P/E-13.2x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks High-Beta Momentum Small-Cap Stocks
Myriad Genetics Inc (MYGN)
Fair Value47.6% Upside Undervalued Analyst68.9% Upside Market Cap303.2 M P/E-2.7x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks High-Beta Momentum Small-Cap Stocks
Eledon Pharmaceuticals Inc (ELDN)
Fair Value-6.9% Downside Fair Analyst161.6% Upside Market Cap269.8 M P/E-3.4x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks High-Beta Momentum
Travere Therapeutics Inc (TVTX)
Fair Value-4.0% Downside Fair Analyst8.9% Upside Market Cap5.281 B P/E-78.0x Yield0.0% HealthGreat
  NASDAQ Featured in Rapid Revenue Growth High-Beta Stocks High-Momentum Stocks High-Beta Momentum
Abeona Therapeutics Inc (ABEO)
Fair Value6.8% Upside Fair Analyst189.9% Upside Market Cap388.7 M P/E5.9x Yield0.0% HealthGood
  NASDAQ Featured in High-Beta Stocks High-Momentum Stocks High-Beta Momentum Small-Cap Stocks
Avalo Therapeutics Inc (AVTX)
Fair Value-7.3% Downside Fair Analyst137.2% Upside Market Cap980.3 M P/E-11.8x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks High-Momentum Stocks High-Beta Momentum Small-Cap Stocks
Fennec Pharmaceuticals Inc (FENC)
Fair Value12.7% Upside Fair Analyst48.9% Upside Market Cap351.2 M P/E-43.6x Yield0.0% HealthGreat
  NASDAQ Featured in High-Beta Stocks High-Momentum Stocks High-Beta Momentum High-Growth Small-Cap Stocks Small-Cap Stocks
Spyre Therapeutics Inc (SYRE)
Fair Value-50.8% Downside Expensive Analyst13.4% Upside Market Cap9.228 B P/E-61.7x Yield0.0% HealthGood
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks High-Momentum Stocks High-Beta Momentum
UroGen Pharma Ltd (URGN)
Fair Value-16.7% Downside Fair Analyst-3.6% Downside Market Cap1.945 B P/E-14.6x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks High-Momentum Stocks High-Beta Momentum
Erasca Inc (ERAS)
Fair Value-18.7% Downside Overvalued Analyst22.4% Upside Market Cap6.38 B P/E-23.3x Yield0.0% HealthGood
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks High-Beta Momentum
Monte Rosa Therapeutics Inc (GLUE)
Fair Value-1.8% Downside Fair Analyst96.5% Upside Market Cap1.358 B P/E-10.1x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks High-Beta Momentum Small-Cap Stocks
Zentalis Pharmaceuticals Llc (ZNTL)
Fair Value13.8% Upside Fair Analyst34.7% Upside Market Cap347.4 M P/E-2.8x Yield0.0% HealthGood
  NASDAQ Featured in High-Beta Stocks High-Beta Momentum High-Growth Small-Cap Stocks Small-Cap Stocks
Alpha Cognition Inc (ACOG)
Fair Value9.5% Upside Fair Analyst87.8% Upside Market Cap194.7 M P/E-7.3x Yield0.0% HealthGood
  NASDAQ Featured in High-Beta Stocks High-Beta Momentum
Grail Inc (GRAL)
Fair Value-26.7% Downside Overvalued Analyst-5.5% Downside Market Cap3.12 B P/E-8.1x Yield0.0% HealthGood
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks High-Beta Momentum
Sagimet Biosciences Inc (SGMT)
Fair Value-31.4% Downside Overvalued Analyst203.2% Upside Market Cap493.4 M P/E-12.3x Yield0.0% HealthGood
  NASDAQ Featured in High-Beta Stocks High-Beta Momentum Small-Cap Stocks
Explore listed stocks on NASDAQ with company information and fair value data.